中外医学研究
中外醫學研究
중외의학연구
Chinese and Foreign Medical Research
2015年
30期
3-5
,共3页
盐酸利托君%硫酸镁%先兆早产
鹽痠利託君%硫痠鎂%先兆早產
염산리탁군%류산미%선조조산
Ritodrine Hydrochloric%Magnesium Sulfate%Threatened premature labor
目的:探讨比较盐酸利托君与硫酸镁防治先兆早产的临床疗效.方法:选取笔者所在医院妇产科2013年1月-2014年12月收治的90例先兆早产患者,将其按照数字表法随机分为研究组和对照组,每组45例.研究组给予盐酸利托君,对照组给予硫酸镁.对比两组患者的起效时间、孕龄延长时间、治疗成功率、不良反应发生率、新生儿存活率、出生体重及Apgar评分的差异.结果:研究组起效时间显著短于对照组(P<0.01),孕龄延长时间明显长于对照组(P<0.01),治疗成功率显著优于对照组(P<0.05);研究组不良反应发生率显著低于对照组(P<0.05);新生儿存活率、出生体重及Apgar评分均优于对照组(P<0.05).结论:盐酸利托君治疗先兆早产的临床疗效明显优于硫酸镁,临床上值得推广应用.
目的:探討比較鹽痠利託君與硫痠鎂防治先兆早產的臨床療效.方法:選取筆者所在醫院婦產科2013年1月-2014年12月收治的90例先兆早產患者,將其按照數字錶法隨機分為研究組和對照組,每組45例.研究組給予鹽痠利託君,對照組給予硫痠鎂.對比兩組患者的起效時間、孕齡延長時間、治療成功率、不良反應髮生率、新生兒存活率、齣生體重及Apgar評分的差異.結果:研究組起效時間顯著短于對照組(P<0.01),孕齡延長時間明顯長于對照組(P<0.01),治療成功率顯著優于對照組(P<0.05);研究組不良反應髮生率顯著低于對照組(P<0.05);新生兒存活率、齣生體重及Apgar評分均優于對照組(P<0.05).結論:鹽痠利託君治療先兆早產的臨床療效明顯優于硫痠鎂,臨床上值得推廣應用.
목적:탐토비교염산리탁군여류산미방치선조조산적림상료효.방법:선취필자소재의원부산과2013년1월-2014년12월수치적90례선조조산환자,장기안조수자표법수궤분위연구조화대조조,매조45례.연구조급여염산리탁군,대조조급여류산미.대비량조환자적기효시간、잉령연장시간、치료성공솔、불량반응발생솔、신생인존활솔、출생체중급Apgar평분적차이.결과:연구조기효시간현저단우대조조(P<0.01),잉령연장시간명현장우대조조(P<0.01),치료성공솔현저우우대조조(P<0.05);연구조불량반응발생솔현저저우대조조(P<0.05);신생인존활솔、출생체중급Apgar평분균우우대조조(P<0.05).결론:염산리탁군치료선조조산적림상료효명현우우류산미,림상상치득추엄응용.
Objective:To compare the clinical effects of ritodrine hydrochloric or magnesium sulfate on the prevention of threatened premature labor.Method:90 cases of patients with threatened premature labor were treated from January 2013 to December 2014 in obstetrics and gynecology of our hospital and randomly divided into the study group and the control group,45 cases in each group.Patients in the study group were treated by Ritodrine Hydrochloric and patients in the control group were treated by Magnesium Sulfate.The onset time,gestational age longer time,the success rate, incidence of adverse reactions,neonatal survival,birth weight and Apgar score were compared between two groups.Result:The onset time in the study group was significantly less than that in the control group(P<0.01).The gestational age longer time in the study group was significantly longer than that in the control group(P<0.01).The clinical success rate in the study group was significantly higher than that in the control group(P<0.05).The adverse reaction rate in the study group was significantly less than that in the control group(P<0.05).The neonatal survival,birth weight and Apgar score in the study group were significantly better than those in the control group(P<0.05).Conclusion:Ritodrine Hydrochloric has a better clinical effects on prevention of threatened premature labor,makes it worth for wildly used.
